METASTATIC MALIGNANT SOLID NEOPLASM
Clinical trials for METASTATIC MALIGNANT SOLID NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new METASTATIC MALIGNANT SOLID NEOPLASM trials appear
Sign up with your email to follow new studies for METASTATIC MALIGNANT SOLID NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise in early cancer trial
Disease control CompletedThis early-phase trial tested a combination of two drugs, sapanisertib and ziv-aflibercept, in 83 adults with advanced solid tumors that had spread or could not be removed by surgery. The main goal was to find the safest dose and identify side effects. The approach aims to slow t…
Matched conditions: METASTATIC MALIGNANT SOLID NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 16, 2026 23:50 UTC
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control CompletedThis early-stage trial tested a new drug (AZD8186) combined with chemotherapy (docetaxel) in 23 people with advanced solid tumors that have certain gene mutations (PTEN or PIK3CB). The main goals were to find the best dose and check for side effects. The study was completed, but …
Matched conditions: METASTATIC MALIGNANT SOLID NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 16, 2026 23:47 UTC
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control CompletedThis early-stage trial tested a new drug called ALRN-6924 combined with the chemotherapy paclitaxel in 28 adults with advanced solid tumors that had spread or couldn't be removed by surgery, including a type of breast cancer. The main goal was to find the safest dose and check fo…
Matched conditions: METASTATIC MALIGNANT SOLID NEOPLASM
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New pill shows promise for rare Gene-Driven cancers
Disease control CompletedThis study tested an oral drug called infigratinib in 17 adults with advanced or metastatic solid tumors that have specific FGFR gene mutations. The goal was to see if the drug could shrink or control the cancer by blocking overactive FGFR proteins. While not a cure, the treatmen…
Matched conditions: METASTATIC MALIGNANT SOLID NEOPLASM
Phase: PHASE2 • Sponsor: Sameek Roychowdhury • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New combo therapy shows promise for Hard-to-Treat cancers
Disease control CompletedThis early-phase trial tested a combination of three drugs—vemurafenib, cetuximab, and irinotecan—in 47 people with advanced solid tumors that have a specific BRAF V600 mutation and have spread or cannot be removed by surgery. The main goal was to find the safest dose and underst…
Matched conditions: METASTATIC MALIGNANT SOLID NEOPLASM
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New immunotherapy cocktail plus radiation shows promise for tough cancers
Disease control CompletedThis study tested a combination of three immunotherapy drugs (ipilimumab, nivolumab, and BMS-986156) with or without precise radiation therapy in 51 adults with advanced solid tumors that had spread to the lung, chest, or liver. The goal was to find the safest dose of BMS-986156 …
Matched conditions: METASTATIC MALIGNANT SOLID NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
Magic mushroom therapy eases cancer fear in early trial
Symptom relief CompletedThis study tested whether a pharmaceutical-grade psilocybin (from magic mushrooms) given in a group therapy setting is safe and can reduce anxiety and depression in people with metastatic cancer. 55 participants received the drug during a therapy session. The main goal was to see…
Matched conditions: METASTATIC MALIGNANT SOLID NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: University of Washington • Aim: Symptom relief
Last updated May 16, 2026 23:36 UTC
-
Second dose of magic mushroom therapy may ease cancer anxiety
Symptom relief CompletedThis study looked at whether a second psilocybin-assisted group therapy session is safe and helpful for people with metastatic cancer who still had anxiety after their first retreat. Fifteen participants who had a partial response to the first retreat took part. The goal was to s…
Matched conditions: METASTATIC MALIGNANT SOLID NEOPLASM
Phase: PHASE1 • Sponsor: University of Washington • Aim: Symptom relief
Last updated May 11, 2026 20:48 UTC
-
New program helps latino cancer patients talk about End-of-Life wishes
Knowledge-focused CompletedThis study tested a program called PLAN to help Latino adults with advanced cancer understand and discuss their future medical care. Twenty-seven people took part to see if the program was helpful and easy to use. The goal was to improve knowledge and communication about advance …
Matched conditions: METASTATIC MALIGNANT SOLID NEOPLASM
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC
-
New website helps cancer patients prepare for end-of-life decisions
Knowledge-focused CompletedThis study tested a new website designed to help people with advanced cancer plan for end-of-life care, including medical wishes, legal documents, and financial tasks. About 100 patients took part to see if the tool made planning easier and reduced distress. The goal was to learn…
Matched conditions: METASTATIC MALIGNANT SOLID NEOPLASM
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Knowledge-focused
Last updated May 14, 2026 12:03 UTC